← Eichor
Study identifier: NCT06349564 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Implementing Virtual Reality (VR) to Reduce Sedation

Condition: Sedative During Endoscopy  ·  Sponsor: NYU Langone Health

PhaseNA
Planned participants10
Who can joinAll sexes, 21 Years to 65 Years
Healthy volunteersYes

About this study

The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.

This description comes directly from the study's public registry record.

Talk to the study team

Maysaa El Zoghbi, MD  ·  216-835-7626  ·  Maysaa.ElZoghbi@nyulangone.org

Gregory Faulx  ·  216-213-7413  ·  gregory.faulx@nyulangone.org

Always discuss trial participation with your own doctor first.

Locations (1)

NYU Langone BrooklynBrooklyn, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06349564